Annual financial impact of well-differentiated thyroid cancer care in the United States

摘要: BACKGROUND Well-differentiated thyroid cancer (WDTC) is a prevalent disease, which increasing in incidence faster than any other cancer. Substantial direct medical care costs are related to the diagnosis and treatment of newly diagnosed patients as well ongoing surveillance who have long life expectancy. Prior analyses aggregate health attributable WDTC United States not been reported. METHODS A stacked cohort cost analysis was performed on US population from 1985 2013 estimate number survivors 2013. Incidence rates, cancer-specific overall survival were based Surveillance, Epidemiology, End Results (SEER) data. Current projected with then estimated. Health care–related event probabilities Medicare reimbursement schedules literature. RESULTS Estimated societal for all after $1.6 billion. Diagnosis, surgery, adjuvant therapy (41%) constitutes greatest proportion costs, followed by (37%), nonoperative death (22%). Projected 2030 (in dollars) current trends exceed $3.5 billion. CONCLUSIONS Health substantial. Unlike cancers, majority incurred initial continuing phases care. With incidence, population, trends, will continue escalate. Cancer 2014;120:1345–1352. © 2014 American Society.